• Thumbnail for Novartis
    Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Consistently ranked in the global top five, Novartis is one...
    144 KB (12,146 words) - 09:25, 31 October 2024
  • Prior to October 2023, it was part of a division of Novartis that was established in 2003, when Novartis united all of its generics businesses under the name...
    35 KB (2,760 words) - 06:06, 18 October 2024
  • Thumbnail for Ovaltine
    acquired the brand from Novartis in 2002, except in the United States, where Nestlé acquired the rights separately from Novartis in the late 2000s. Ovaltine...
    16 KB (1,642 words) - 03:19, 10 November 2024
  • AveXis was acquired by Novartis in 2018 for USD 8.7 billion. In September 2020, Novartis changed the company's name to Novartis Gene Therapies. In 2019...
    10 KB (784 words) - 22:30, 12 September 2024
  • Thumbnail for Alcon
    Alcon (category Novartis)
    2008, Novartis purchased approximately 25% of Nestlé's stake in Alcon, with an option to buy Nestlé's remaining shares beginning in 2010. Novartis bought...
    13 KB (966 words) - 07:56, 21 October 2024
  • Thumbnail for Imatinib
    Imatinib (category Drugs developed by Novartis)
    sold under the brand names Gleevec and Glivec (both marketed worldwide by Novartis) among others, is an oral targeted therapy medication used to treat cancer...
    71 KB (6,702 words) - 05:32, 9 August 2024
  • Thumbnail for Novartis v. Union of India & Others
    Novartis v. Union of India & Others is a landmark decision by a two-judge bench of the Indian Supreme Court on the issue of whether Novartis could patent...
    43 KB (5,300 words) - 23:28, 21 October 2024
  • Thumbnail for Maalox
    In February 2012, Novartis Consumer Health announced that they were temporarily, voluntarily suspending operations at the Novartis Consumer Health Lincoln...
    10 KB (1,153 words) - 15:46, 3 October 2024
  • The Novartis-Drew Award for Biomedical Research is an award jointly presented by Novartis and Drew University. It comprises a cash award (originally $2000)...
    7 KB (571 words) - 18:34, 17 September 2024
  • Thumbnail for Vasant Narasimhan
    Vasant Narasimhan (category Novartis people)
    officer of Novartis. He succeeded Joseph Jimenez who left Novartis in 2018. He briefly worked at McKinsey Swiss Intel, canlgnd before joining Novartis in 2005...
    22 KB (1,892 words) - 02:29, 30 October 2024
  • com. "Novartis Financial Results Q4 2023" (PDF). "Novartis Financial Results Q4 2022" (PDF). Media release 2021 Novartis Media release 2019 Novartis Media...
    62 KB (2,735 words) - 16:33, 29 August 2024
  • Thumbnail for Secukinumab
    Secukinumab (category Drugs developed by Novartis)
    arthritis. It binds to the protein interleukin (IL)-17A and is marketed by Novartis. Secukinumab is used to treat psoriasis, ankylosing spondylitis, and psoriatic...
    17 KB (1,245 words) - 14:04, 2 September 2024
  • combined to form Novartis Vaccines and Diagnostics, while Chiron BioPharmaceuticals was integrated into Novartis Pharmaceuticals. In 2014, Novartis completed...
    23 KB (2,299 words) - 20:32, 15 April 2024
  • the 1990s by researchers at Chiron Corporation, a Novartis heritage company, acquired by Novartis in 2006. AS03, another squalene based adjuvant O’Hagan...
    2 KB (236 words) - 19:26, 3 February 2023
  • The Novartis Foundation (formerly known as the Novartis Foundation for Sustainable Development) is a non-profit organization and part of the corporate...
    5 KB (488 words) - 07:51, 21 April 2024
  • Thumbnail for Excedrin (brand)
    majority ownership through a joint venture transaction with Novartis. On January 9, 2012, Novartis announced that it was voluntarily recalling all lots of...
    14 KB (1,370 words) - 22:49, 11 October 2024
  • to form Novartis. At Sandoz, he worked in research and development and became head of development in 1994. Following the merger into Novartis, Reinhardt...
    5 KB (458 words) - 09:42, 22 September 2024
  • Thumbnail for Peter Piot
    Trustees Novartis Foundation. Novartis Foundation confirms new members of its Board of trustees, including new Chairman Dr. Joerg Reinhardt Novartis Foundation...
    34 KB (3,204 words) - 14:27, 7 October 2024
  • premium. On January 22, 2018, Novartis AG announced the successful completion of the tender offer by its subsidiary, Novartis Groupe France S.A. AAA was...
    20 KB (1,768 words) - 18:07, 12 September 2024
  • Artemether/lumefantrine (category Drugs developed by Novartis)
    supplies of Coartem met demand which enabled Novartis to further decrease the price of Coartem. In April 2008, Novartis further reduced the public sector price...
    12 KB (1,164 words) - 01:18, 21 April 2024
  • "Laureates". Novartis Prizes for Immunology. 3 October 2011. Archived from the original on 29 August 2018. Retrieved 29 August 2018. "The Prizes". Novartis Prizes...
    2 KB (190 words) - 15:37, 26 November 2023
  • Thumbnail for Nepafenac
    Nepafenac (category Drugs developed by Novartis)
    6, 2008, Novartis agreed to purchase approximately 74 million shares of Alcon from Nestlé at $143.18 per share. On January 4, 2010, Novartis agreed to...
    20 KB (1,715 words) - 08:12, 1 November 2024
  • Onasemnogene abeparvovec (category Drugs developed by Novartis)
    whistleblower informed Novartis that certain studies of the medication had been subject to data manipulation. In a filing to the FDA, Novartis said that two executives...
    33 KB (2,436 words) - 22:34, 5 November 2024
  • Thumbnail for Joseph Jimenez
    Joseph Jimenez (category Novartis people)
    an advisor for the Blackstone Group. Jimenez joined Novartis in 2007 as Division Head of Novartis Pharmaceutical and was named CEO in 2010 by his predecessor...
    8 KB (599 words) - 09:59, 25 July 2024
  • Thumbnail for Paul Hudson (businessman)
    Paul Hudson (businessman) (category Novartis people)
    Team". Fiercepharma. "Novartis focuses Pharmaceuticals Division by creating two business units, Novartis Pharmaceuticals and Novartis Oncology; appoints...
    5 KB (242 words) - 19:44, 18 July 2024
  • ease restrictions on the supply of Ritalin to help increase profits for Novartis. Beginning in the 1980s, a series of lawsuits were filed based on the perceived...
    8 KB (1,018 words) - 10:50, 19 December 2023
  • Thumbnail for Iptacopan
    Iptacopan (category Drugs developed by Novartis)
    hemoglobinuria (PNH). It is a complement factor B inhibitor that was developed by Novartis. It is taken by mouth. Iptacopan was approved by the US Food and Drug Administration...
    13 KB (816 words) - 02:44, 12 October 2024
  • Thumbnail for Everolimus
    Everolimus (category Drugs developed by Novartis)
    sorafenib" (Press release). Novartis. 30 March 2009. Archived from the original on 3 April 2009. Retrieved 6 April 2009. "Novartis receives US FDA approval...
    27 KB (2,534 words) - 20:49, 4 October 2024
  • global plant", Grimsby Telegraph, 16 August 2011, retrieved 23 August 2014 "Novartis Active Pharmaceutical Ingredients, United Kingdom", www.pharmaceutical-technology...
    79 KB (6,401 words) - 20:56, 12 September 2024
  • Thumbnail for List of seasonal influenza vaccines
    List of seasonal influenza vaccines (category Drugs developed by Novartis)
    inactivated vaccine prepared in cell cultures manufactured by Novartis. In April 2007, Novartis received a positive opinion supporting European Union approval...
    22 KB (2,049 words) - 05:50, 21 October 2024